Pee Safe raises $3 million in a Series B funding round led by Natco Pharma and Rainmatter Health
Pee Safe, a hygiene and wellness brand has raised $3 million in a Series B funding round led by Natco Pharma Limited, and Rainmatter Health. Nithin Kamath and Nikhil Kamath, founders of Zerodha. Alkemi Growth Capital, an existing investor, also participated in the round.
«This funding will accelerate our expansion efforts and establish us as the leading brand in the rapidly growing intimate wellness sector, which boasts a remarkable CAGR of 16%,” Vikas Bagaria, founder and CEO of Pee Safe adding that over the past five years, the brand has achieved a growth rate of 100% CAGR, surpassing market expectations.
Enhance Your Healthcare Expertise with High-Impact Courses
Offering CollegeCourseWebsiteIndian School of BusinessISB Healthcare ManagementVisitIIM KozhikodeIIMK Healthcare Management & Analytics ProgrammeVisitOriginally launched in 2013 with just one product, a toilet seat sanitizer by Vikas Bagaria, and Srijana Bagaria (husband-wife duo) out of a personal incident, Pee Safe has evolved into a personal hygiene and fast-moving consumer goods (FMCG) brand. In the past six years, the company has diversified its product range to include personal hygiene categories, addressing the needs of girls from puberty to menopause. The portfolio has intimate hygiene products such as reusable pads, tampons, menstrual cups, and more.
Earlier this year, the company elevated Rithish Kumar, one of the early founding members as the co-founder. The company said the newly acquired funds will be utilized to expand retail presence in India, expand overseas with an omni-channel approach and allocate additional resources to marketing and awareness initiatives.
Currently, the company’s products are available in over 15,000 physical retail stores
